Hikma Injectables USA Inc recalls phenylephrine in 0.9% Sodium Chloride Inj, 1mg per 10 mL (100 mcg/mL), Rx only, Hikma Injectables USA Inc., 36 Stults Ro
Recalled January 8, 2025 · FDA recall D-0174-2025 · Hikma Injectables USA
Hazard
Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment. · FDA Class II
Sold at
Nationwide in the USA
Description
Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.
Product
phenylephrine in 0.9% Sodium Chloride Inj, 1mg per 10 mL (100 mcg/mL), Rx only, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, NDC 63037-173-25
Manufacturer(s)
Hikma Injectables USA Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →